Recursion Pharmaceuticals, Inc. (BIVA:RXRX) IPO

Recursion Pharmaceuticals, Inc.

IPO

Priced at US$18.00 a share on Apr 15, 2021.

Price
US$18.00 a share
Shares offered
24,242,424 shares of Class A common stock
Offering size
US$436.4 million
Underwriters' option
Up to 3,636,363 more shares
Underwriters
Goldman Sachs & Co. LLC, J.P. Morgan, BofA Securities, SVB Leerink, Allen & Company LLC, KeyBanc Capital Markets · In the order on the cover
Shares delivered
On or about Apr 20, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceJan 26, 2021
Filed publiclyMar 22, 2021
Amended twiceNewest Apr 15, 2021
Shares registered with an exchangeApr 12, 2021
Declared effective by the SECApr 15, 2021
Final prospectus, with the priceApr 16, 2021

From the cover of the final prospectus (424B4) filed Apr 16, 2021